4 research outputs found
Serious adverse events (SAE) reported for the period 1–5 months after the 2009 AS03-adjuvanted monovalent pandemic vaccine.
<p>Serious adverse events (SAE) reported for the period 1–5 months after the 2009 AS03-adjuvanted monovalent pandemic vaccine.</p
Paresthesia of sufficient enough to cause work/school absenteeism or a medical consultation after the 2009 pandemic vaccine.
<p>Paresthesia of sufficient enough to cause work/school absenteeism or a medical consultation after the 2009 pandemic vaccine.</p
Characteristics of the health care workers vaccinated with the monovalent 2009 AS03-adjuvanted pandemic vaccine or the 2010–2011 trivalent inactivated seasonal vaccine.
*<p>For 2009 this information was collected in only one site.</p><p>NA: Not available.</p
New health problem or the worsening of an existing condition of sufficient significance to cause a medical consult and/or work absenteeism by follow-up period and type of influenza vaccine.
*<p>These local reactions started in the 0–7 day period post vaccination but were reported in the 8–28 day survey.</p